进展型多发性硬化丘脑损伤的「室管膜向内」梯度
研究对比41例继发进展型多发性硬化尸检丘脑背内侧核与脑脊液样本、5例非神经科对照及12例其他神经疾病对照,发现多发性硬化丘脑病灶存在自室管膜/脑脊液边界向内递减的神经元与轴突丢失梯度,以及与之反向的小胶质细胞活化梯度,该梯度与快速严重进展、室管膜下浸润及脑脊液炎症因子相关。
要点
- 多发性硬化丘脑病灶NeuN+神经元密度自室管膜/脑脊液边界向内递减,边界处减少26%,10 mm处减少12%。
- SMI31+轴突密度在距边界2 mm处减少38%,10 mm处减少13%。
- MHC-II+小胶质细胞密度在2 mm处增加超过50%,10 mm处仅增加15%,与神经元和轴突改变呈反向相关。
核心结论
- 多发性硬化丘脑存在显著的「室管膜向内」病理细胞改变梯度,伴随鞘内炎症(局限于室管膜下淋巴样血管周围浸润或脑脊液),可能在多发性硬化进展中起关键作用。
研究设计与样本
- 研究纳入41例继发进展型多发性硬化尸检丘脑背内侧核及配对脑脊液样本,与5例非神经科对照和12例其他神经疾病对照进行比较。
主要发现
- 多发性硬化丘脑病灶NeuN+神经元密度呈室管膜/脑脊液朝向梯度减少,边界处减少26%,10 mm处减少12%。
- SMI31+轴突密度梯度减少,距室管膜/脑脊液边界2 mm处减少38%,10 mm处减少13%。
- MHC-II+小胶质细胞密度梯度增加,2 mm处增加超过50%,10 mm处仅增加15%,与神经元改变(R=-0.91,p<0.0001)和轴突改变(R=-0.79,p<0.0001)呈反向相关。
- 上述梯度也见于正常表现丘脑,并与快速/严重疾病进展、软脑膜三级淋巴样结构、富含CD20+ B细胞的大型室管膜下浸润及脑脊液炎症/神经变性因子高表达相关。
临床怎么用
- 作者认为脑脊液生物标志物联合先进影像工具可能有助于不仅改善疾病诊断,还早期识别可从更个性化治疗中获益的特定多发性硬化亚组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Leptomeningeal and perivenular infiltrates are important contributors to cortical grey matter damage and disease progression in multiple sclerosis (MS). Whereas perivenular inflammation induces vasculocentric lesions, leptomeningeal involvement follows a subpial "surface-in" gradient. To determine whether similar gradient of damage occurs in deep grey matter nuclei, we examined the dorsomedial thalamic nuclei and cerebrospinal fluid (CSF) samples from 41 postmortem secondary progressive MS cases compared with 5 non-neurological controls and 12 controls with other neurological diseases. CSF/ependyma-oriented gradient of reduction in NeuN+ neuron density was present in MS thalamic lesions compared to controls, greatest (26%) in subventricular locations at the ependyma/CSF boundary and least with increasing distance (12% at 10 mm). Concomitant graded reduction in SMI31+ axon density was observed, greatest (38%) at 2 mm from the ependyma/CSF boundary and least at 10 mm (13%). Conversely, gradient of major histocompatibility complex (MHC)-II+ microglia density increased by over 50% at 2 mm at the ependyma/CSF boundary and only by 15% at 10 mm and this gradient inversely correlated with the neuronal (R = -0.91, p < 0.0001) and axonal (R = -0.79, p < 0.0001) thalamic changes. Observed gradients were also detected in normal-appearing thalamus and were associated with rapid/severe disease progression; presence of leptomeningeal tertiary lymphoid-like structures; large subependymal infiltrates, enriched in CD20+ B cells and occasionally containing CXCL13+ CD35+ follicular dendritic cells; and high CSF protein expression of a complex pattern of soluble inflammatory/neurodegeneration factors, including chitinase-3-like-1, TNFR1, parvalbumin, neurofilament-light-chains and TNF. Substantial "ependymal-in" gradient of pathological cell alterations, accompanied by presence of intrathecal inflammation, compartmentalized either in subependymal lymphoid perivascular infiltrates or in CSF, may play a key role in MS progression. SUMMARY FOR SOCIAL MEDIA: Imaging and neuropathological evidences demonstrated the unique feature of "surface-in" gradient of damage in multiple sclerosis (MS) since early pediatric stages, often associated with more severe brain atrophy and disease progression. In particular, increased inflammation in the cerebral meninges has been shown to be strictly associated with an MS-specific gradient of neuronal, astrocyte, and oligodendrocyte loss accompanied by microglial activation in subpial cortical layers, which is not directly related to demyelination. To determine whether a similar gradient of damage occurs in deep grey matter nuclei, we examined the potential neuronal and microglia alterations in the dorsomedial thalamic nuclei from postmortem secondary progressive MS cases in combination with detailed neuropathological characterization of the inflammatory features and protein profiling of paired CSF samples. We observed a substantial "subependymal-in" gradient of neuro-axonal loss and microglia activation in active thalamic lesions of progressive MS cases, in particular in the presence of increased leptomeningeal and cerebrospinal fluid (CSF) inflammation. This altered graded pathology was found associated with more severe and rapid progressive MS and increased inflammatory degree either in large perivascular subependymal infiltrates, enriched in B cells, or within the paired CSF, in particular with elevated levels of a complex pattern of soluble inflammatory and neurodegeneration factors, including chitinase 3-like-1, TNFR1, parvalbumin, neurofilament light-chains and TNF. These data support a key role for chronic, intrathecally compartmentalized inflammation in specific disease endophenotypes. CSF biomarkers, together with advance imaging tools, may therefore help to improve not only the disease diagnosis but also the early identification of specific MS subgroups that would benefit of more personalized treatments. ANN NEUROL 2022;92:670-685.
引用
- Magliozzi R, Fadda G, Brown RA, et al. "Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis. Ann Neurol. 2022. PMID: 35748636. doi:10.1002/ana.26448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。